Abstract
Cefoxitin, a β-lactamase-resistant cephalosporin, was found to be more effective than cephalothin against an experimental mixed infection containing Bacteroides fragilis and Fusobacterium necrophorum.
Full text
PDF![224](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88d1/429293/1afb9dde1bd1/aac00326-0122.png)
![225](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88d1/429293/e10f6d53e933/aac00326-0123.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hackman A. S., Wilkins T. D. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis. Antimicrob Agents Chemother. 1975 May;7(5):698–703. doi: 10.1128/aac.7.5.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallick H., Hendlin D. Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies. Antimicrob Agents Chemother. 1974 Jan;5(1):25–32. doi: 10.1128/aac.5.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkins T. D., Smith L. D. Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice. Antimicrob Agents Chemother. 1974 Jun;5(6):658–662. doi: 10.1128/aac.5.6.658. [DOI] [PMC free article] [PubMed] [Google Scholar]